Skip to main content
INDP
NASDAQ Life Sciences

Indaptus Posts $1.0M Q3 Loss, Pivots Toward Sleep-Device Research With $30.6M in Liquidity

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$3.17
Mkt Cap
$486.853M
52W Low
$0.92
52W High
$5.96
52W Position info
245% above low
Off High info
47% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

INDP has more than doubled off its 52-week low of $0.92 on light trading volume (0.1× avg).

Summary

Indaptus reported a Q3 2026 net loss of about $1.0 million versus $3.0 million a year earlier, with R&D spending down 82% to roughly $0.3 million after the Decoy20 Phase 1 wind-down and headcount cuts. The company ended September 30 with about $26.6 million in cash plus $4.0 million in CDs, and collected the remaining $3.5 million of its $24.0 million private placement in October, which management says funds operations for at least a year. The bigger story is strategy: with no active clinical programs, the CEO is steering the company toward early-stage research on a neurotechnology and neural-network-based device for sleep-related conditions, with a possible future FDA submission. That is a speculative, pre-preclinical direction funded by heavy dilution — shares outstanding jumped to 133.2 million from 2.2 million at year-end 2025. The going-concern doubt is gone, but the equity story now rests on a sleep device concept rather than the Decoy immunotherapy platform.

At the time of this announcement, INDP was trading at $3.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $486.9M. The 52-week trading range was $0.92 to $5.96. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

INDP - Latest Insights

INDP
Nov 13, 2026, 8:30 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.15
Real-time Price: $3.23 info
Change: +$0.080 (+3%) info
Market Cap: $486.853M info
INDP
Sep 09, 2026, 9:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.11
Real-time Price: $3.23 info
Change: +$1.12 (+53%) info
Market Cap: $486.853M info
INDP
Aug 31, 2026, 9:25 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $1.14
Real-time Price: $3.23 info
Change: +$2.09 (+183%) info
Market Cap: $486.853M info
INDP
Aug 26, 2026, 4:35 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $1.16
Real-time Price: $3.23 info
Change: +$2.07 (+178%) info
Market Cap: $486.853M info
INDP
Aug 17, 2026, 5:00 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $3.23 info
Change: +$2.23 (+223%) info
Market Cap: $486.853M info